Lung Cancer Home > Tarceva and Lung Cancer

Tarceva® (erlotinib) is a cancer medication that comes in the form of a tablet. It is taken daily and is approved to treat non-small cell lung cancer in adults.
 
There are two main types of lung cancer: small cell lung cancer and non-small cell lung cancer. Non-small cell lung cancer is the more common type. It generally spreads more slowly than small cell lung cancer. Tarceva is specifically approved for non-small cell lung cancer that has advanced or spread to other areas of the body (has metastasized).
 
When used for non-small cell lung cancer, Tarceva is not intended to be taken with other chemotherapy medications.
 
(Click Tarceva Uses for more details on this topic, including information on other approved uses, how it works, and possible "off-label" uses.)
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Advertisement
Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.